Home | Coriolis Pharma

Coriolis Pharma Formulating innovation

For us innovation is progress achieved by collaboration. We generate innovation by combining technologies, knowledge and experience.

Formulating for us means to find the right solution.

About us

Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a family-owned and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our customers.

Formulation Development

“It is a medicine, not a molecule, that we are giving to the patient” Marc B. Brown, 2005.

Coriolis is the expert in developing liquid and lyophilized formulations for a large variety of different (bio)pharmaceutical molecules.

Find out how we can support your drug development...

Analytical Capabilities

A highly diverse analytical portfolio entirely performed in-house: This is Coriolis.

With the latest in technology and highly experienced scientists, we are a trendsetter in the field.

Get to know our services...

About us

Independent, reliable and always on the cutting edge of science. Coriolis is the leading service provider for formulation research and development of (bio)pharmaceutical drugs and vaccines.

Get to know us...

Latest news

2019/05/17

Coriolis has a new website!

2019/02/15

Coriolis scientists contribute in new scientific book

View all

Latest publications

Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.

Helbig C, Ammann G, Menzen T, Friess W, Wuchner K, Hawe A.

Comparison of ice fog methods and monitoring of controlled nucleation success after freeze-drying.

Vollrath I, Friess W, Freitag A, Hawe A, Winter G.

Quantitative Laser Diffraction for Quantification of Protein Aggregates: Comparison With Resonant Mass Measurement, Nanoparticle Tracking Analysis, Flow Imaging, and Light Obscuration

Yoneda S, Niederleitner B, Wiggenhorn M, Koga H, Totoki S, Krayukhina E, Friess W, Uchiyama S.

Critical Evaluation of Microfluidic Resistive Pulse Sensing for Quantification and Sizing of Nanometer- and Micrometer-Sized Particles in Biopharmaceutical Products

Grabarek AD, Weinbuch D, Jiskoot W, Hawe A.

Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation

Kranz W, Wuchner K, Corradini E, Berger M, Hawe A.

High-Resolution Asymmetrical Flow Field-Flow Fractionation Data Evaluation via Richardson-Lucy-Based Fractogram Correction

Schmid M, Häusele B, Junk M, Brookes E, Frank J, Cölfen H.

PWWP2A binds distinct chromatin moieties and interacts with an MTA1-specific core NuRD complex

Link S, Spitzer RMM, Sana M, Torrado M, Völker-Albert MC, Keilhauer EC, Burgold T, Pünzeler S, Low JKK, Lindström I, Nist A, Regnard C, Stiewe T, Hendrich B, Imhof A, Mann M, Mackay JP, Bartkuhn M, Hake SB.

Does controlled nucleation impact the properties and stability of lyophilized monoclonal antibody formulations?

Vollrath I, Friess W, Freitag A, Hawe A, Winter G.

Baculovirus-driven protein expression in insect cells: A benchmarking study

Stolt-Bergner P, Benda C, Bergbrede T, Besir H, Celie PHN, Chang C, Drechsel D, Fischer A, Geerlof A, Giabbai B, van den Heuvel J, Huber G, Knecht W, Lehner A, Lemaitre R, Nordén K, Pardee G, Racke I, Remans K, Sander A, Scholz J, Stadnik M, Storici P, Weinbruch D, Zaror I, Lua LHL, Suppmann S.

Engineered hybrid spider silk particles as delivery system for peptide vaccines

Lucke M, Mottas I, Herbst T, Hotz C, Römer L, Schierling M, Herold HM, Slotta U, Spinetti T, Scheibel T, Winter G, Bourquin C, Engert J.

View all